CLINICAL_TRIALS
trial_result
· 2009-11-10
Clinical Trial Update: Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease [Phase 2]
Summary
Phase 2 maintenance study of certolizumab pegol in Crohn's disease completed; results were posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Japan Co. Ltd. | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2009-11-10